Home›Psychiatry› Misoprostol and oxytocin show comparable effectiveness for postpartum hemorrhage in Nigerian review
Misoprostol and oxytocin show comparable effectiveness for postpartum hemorrhage in Nigerian reviewNew Research Shows Better Ways to Manage Postpartum Hemorrhage
Frontiers in MedicinePublished August 18, 2026Study authors: Melody Ucho, Princess Okelu, Sarim Faheem, Iretioluwa Adeola, Adwoa Ansong, Dorice Vieira, Nessa Rya…DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider implementation context when applying PPH interventions; evidence gaps remain in primary care.
This systematic review synthesized 31 studies, including 20 randomized controlled trials, 8 observational studies, 2 mixed-methods studies, and 1 qualitative study, conducted in tertiary facilities in Nigeria. The review focused on implementation research outcomes for postpartum hemorrhage (PPH) prevention and management, including adoption, sustainability, fidelity, and effectiveness.
For clinical interventions, the review found that misoprostol and oxytocin had comparable effectiveness for low-risk women. Device-based interventions, such as the non-pneumatic anti-shock garment, were associated with improved stabilization and reduced mortality. Healthcare systems-level interventions, including the E-MOTIVE bundle and active management of the third stage of labor (AMTSL), demonstrated high adoption and were associated with reductions in severe PPH.
The authors noted significant gaps in the evaluation and reporting of implementation science outcomes, a lack of assessment of the patient's perspective, and limited implementation evaluation in primary-level care settings. They also highlighted a substantial lack of evidence in regions with high burden of PPH mortality.
Overall risk of bias was low-to-moderate. The review's findings are associations, not causal, for device-based and systems-level interventions. The translation of effective PPH interventions may be constrained by limited implementation evaluation in Nigeria, particularly in primary-level care settings.
How this fits prior evidence
This review confirms prior evidence that tranexamic acid reduces postpartum haemorrhage in placenta praevia caesarean delivery, extending it by showing comparable effectiveness of misoprostol and oxytocin in Nigerian settings. It also aligns with prior findings on anesthesia and PPH risk, reinforcing the importance of context-specific interventions. The review addresses a gap by focusing on implementation outcomes, but notes limited evidence from primary-level care, which prior coverage did not address.
A review of 31 different studies looked at ways to prevent and manage postpartum hemorrhage, which is severe bleeding after giving birth. The study focused on women in tertiary hospitals in Nigeria. Researchers looked at several methods, including medications like misoprostol and oxytocin, as well as specialized equipment and healthcare protocols.
The findings showed that for low-risk women, misoprostol and oxytocin were equally effective. Additionally, the use of a non-pneumatic anti-shock garment was linked to better stabilization and lower death rates. Certain healthcare systems, such as the E-MOTIVE bundle and AMTSL protocols, also showed high adoption and helped reduce cases of severe bleeding.
It is important to note that these findings mostly come from large hospitals. There is currently very little information on how these treatments work in smaller, primary-level clinics. Because the evidence for some methods is limited by where they were tested, patients and doctors should discuss specific treatment plans based on local resources.
What this means for you:
Certain medical bundles and devices show promise in managing severe bleeding after childbirth in hospital settings.
Common questions
Are misoprostol and oxytocin equally effective?
The review of 31 studies found that misoprostol and oxytocin showed comparable effectiveness for treating low-risk women who experience bleeding after giving birth. Both medications are common tools used in managing postpartum hemorrhage.
What role do special garments play in treatment?
The use of a non-pneumatic anti-shock garment was associated with improved stabilization and reduced mortality for women experiencing heavy bleeding after childbirth. This device is one of several interventions studied to improve patient outcomes.
Are these treatments available in all clinics?
The study noted a lack of data regarding primary-level care settings. Most evidence came from tertiary facilities, meaning there is currently less information on how these specific interventions perform in smaller community clinics.
Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality globally and in Nigeria. Although clinical interventions may address PPH, less is known about their implementation within routine health systems. The objective of this systematic review was to synthesize the implementation research outcomes of interventions for PPH prevention and management in Nigeria for healthcare providers and patients.
This systematic review of interventions for PPH in Nigeria searched seven electronic databases (i.e., Embase, Web of Science, MEDLINE, Global Health, Cochrane Library, PubMed, and PAIS) without date restrictions. Peer-reviewed studies reporting implementation and service outcomes, including adoption, sustainability, fidelity, and effectiveness, were included. Data were extracted on intervention type, setting, implementation, service and client outcomes. Risk of bias was assessed and visualized (via ROBVIS tool).
Of the 1,255 articles retrieved, 31 met the inclusion criteria, including 20 randomized controlled trials, eight observational, two mixed-methods, and one qualitative study. Most were conducted in tertiary facilities; none exclusively focused on primary-level care. Clinical interventions were mostly reported (n = 25). Evidence suggested comparable effectiveness between misoprostol and oxytocin for low-risk women. Device-based interventions, including the non-pneumatic anti-shock garment, were associated with improved stabilization and reduced mortality. Healthcare Systems-level interventions that include standardized care protocols in clinical management of PPH, particularly multicomponent bundled interventions such as the E-MOTIVE bundle and AMTSL, demonstrated high adoption and were associated with reductions in severe PPH. Implementation outcomes were infrequently reported (5 of 31 articles). Overall risk of bias was low-to-moderate.
There was a notable gap in the evaluation and reporting of IS outcomes as well as the assessment of the patient's perspective from the receipt of interventions. Translation of effective PPH interventions may be constrained by limited implementation evaluation in Nigeria, particularly in primary-level care settings. Substantial lack of evidence exists in regions that bear a disproportionately high burden of PPH mortality.
Open Science Framework (DOI 10.17605/OSF.IO/CYS2M).
